Effect of ?Selenium on controlling clinical symptoms in rheumatoid arthritis Patients

Phase 2

Recruiting

• Conditions: Rheumatoid arthritis.; Rheumatoid arthritis, unspecified; M06.9

• Registration Number: IRCT20161204031229N4
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Active disease at the time of enrollment
Stable renal function
No liver dysfunction
Ability to receive oral medication

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment of clinical symptoms. Timepoint: Before studying, after 12 months. Method of measurement: Disease Activity Score, version 28 questionnaire.